Nevada's Assembly Bill 522 is set to reshape maternal health coverage in the state, mandating comprehensive insurance benefits for pregnant individuals. Introduced on April 24, 2025, the bill requires health insurance policies to include essential services such as daily folic acid supplements, low-dose aspirin for preeclampsia prevention, and screenings for asymptomatic bacteriuria during pregnancy.

The legislation aims to address critical gaps in maternal healthcare, particularly for those at high risk of complications. By ensuring coverage for preventive measures and counseling related to weight management and mental health, the bill seeks to improve outcomes for mothers and their newborns. Notably, it also includes provisions for prophylactic treatments to prevent gonococcal ophthalmia in infants, highlighting a proactive approach to maternal and child health.

Debate surrounding AB 522 has centered on the implications of mandated coverage. Supporters argue that the bill is a necessary step toward reducing maternal morbidity and mortality rates, while opponents raise concerns about potential increases in insurance premiums and the burden on healthcare providers. Amendments to the bill have been proposed to clarify the use of medical management techniques, which allow insurers to control costs while still providing necessary care.

The economic implications of AB 522 could be significant, as improved maternal health can lead to lower long-term healthcare costs and better workforce participation among mothers. Experts suggest that by investing in preventive care now, Nevada could see substantial benefits in the future, both socially and economically.

As the bill moves through the legislative process, its passage could mark a pivotal moment for maternal health policy in Nevada, setting a precedent for other states to follow. If enacted, AB 522 will take effect on October 1, 2025, ensuring that pregnant individuals receive the comprehensive care they need to support healthy pregnancies and outcomes.